Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
PRVL | Prevail Therapeutics Inc. | Tyto Acquisition Corp | 10% Owner | Jan 22, 2021 | Buy | $22.50 | 34,284,789 | 771,407,753 | 100 | Jan 22, 2021, 04:26 PM | |
PRVL | Prevail Therapeutics Inc. | Abeliovich Asa | President & CEO | Dec 30, 2020 | Option Exercise | $15.30 | 214,830 | 3,287,288 | 2,474,793 | Dec 31, 2020, 04:54 PM | |
PRVL | Prevail Therapeutics Inc. | Minkow Emily | Chief Business Officer | Dec 24, 2019 | Option Exercise | $0.18 | 13,000 | 2,340 | 13,000 | Mar 11, 2020, 04:47 PM | |
PRVL | Prevail Therapeutics Inc. | Thompson Peter A. | Director | Jun 24, 2019 | Buy | $17.00 | 882,352 | 14,999,984 | 13,822,463 | Jun 26, 2019, 04:56 PM | |
PRVL | Prevail Therapeutics Inc. | GORDON CARL L | Director | Jun 24, 2019 | Buy | $17.00 | 882,352 | 14,999,984 | 13,822,463 | Jun 26, 2019, 04:55 PM | |
PRVL | Prevail Therapeutics Inc. | ORBIMED ADVISORS LLC | Director | Jun 24, 2019 | Buy | $17.00 | 882,352 | 14,999,984 | 13,822,463 | Jun 26, 2019, 04:54 PM |